Is Clover Health Stock Too Dependent On One Group Of Members?
During an August 5, 2026 call, management at Clover Health Investments (CLOV) noted that nearly half of its Medicare Advantage members joined the company in 2025 or 2026. That matters because Clover typically earns less gross profit on a member in the first year than in the second, and the 2026 cohort is still navigating that initial period. Even so, the stock has returned 70% over the past twelve months, compared to 17.0% for the S&P 500. So where are all these new members coming from?

Why Does Clover Have So Many New Members?
During the second quarter of fiscal 2026, Clover’s Medicare Advantage membership grew 48% from a year earlier to reach an average of 157,000. Members who joined in 2026 account for about 28% of the total, while those who signed up in 2025 represent about 21%.
Management indicated that this growth is concentrated in its core markets, which include New Jersey. Those regions experienced significant disruption in 2025 and 2026, and the company framed its bids assuming more market turbulence is ahead. Clover announced its 2027 plans on October 1, 2026. If the regional disruption continues, another large intake of newcomers may follow.
What Do New Members Do To Clover’s Profit?
An influx of new members holds Clover’s profit down in their first year of coverage. Management explained that a single member typically generates about $70 more gross profit each month during their second year compared to their first. It said that keeping members enrolled longer remains the most important financial driver for Clover.
Over the past twelve months, Clover lost 0.7% of revenue. During that same period, the S&P 500 posted a profit of 13.2% of revenue.
There is some evidence pointing the other way, though. According to management, medical costs are currently running better than the company expected at the start of the year. Hospital stays are also trending favorably, and that improvement includes the first-year members. Second-quarter gross profit grew 54%, outpacing the 48% growth in membership. However, gross profit still expanded more slowly than revenue, which rose 56%.
Management raised its full-year guidance on every measure. Yet the company also cautioned that it wants to see more claims materialize before assuming these trends will last through the end of the year.
Clover Stock Has Dropped More Than The Market Before
Holders have also seen how far Clover stock can fall. It fell 65% in the 2022 inflation shock, against a 24% drop for the S&P 500. When the 2025 tariff shock hit, the stock fell 37%, compared to a 19% decline for the index.
Right now, Clover stock sells for 1.0 times sales, against 3.0 for the S&P 500. But Clover lost money over the past twelve months while the broader index earned a profit. The stock has also climbed sharply over the past year, so a lower multiple may not mean the worry is in the price.
A holder has reason to be moderately worried, and no more than that. On the positive side, Clover has no debt, and its adjusted EBITDA was positive in the second quarter. On the negative side, management expects the business to turn to a seasonal loss in the fourth quarter. This underlying worry would ease if the members who joined in 2025 and 2026 bring in more profit each year. If the third-quarter report shows gross profit again growing faster than membership, it would suggest Clover is earning more on those members the longer they stay.
How To Act On CLOV?
Now you know CLOV better. And that’s our purpose: to make you informed before you invest your money. However, making a bet on a single stock carries its own risks.
There is a smarter choice. Since its inception, the Trefis High Quality (HQ) Portfolio has beaten the benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. And it did so without taking the concentrated risk that comes with do-it-yourself stock picking.
If you’d rather act on CLOV itself:
| Play Offense | Play Defense |
|---|---|
| Learn More About CLOV & Invest | Save Taxes On Capital Gain |
| Earn From CLOV Cash Secured Puts | Covered Call Against CLOV |